Company intelligence / Profile preview

Testie Health

Los Angeles, California, United States

Ownership: Private
Development stage: Other

Overview

Testie is a men's health company focused on the early detection of testicular cancer through accessible at-home screening tools. The company's flagship product, the Testie, is a specialized device designed to assist men in performing regular and accurate testicular self-exams. By combining hardware with educational resources, Testie aims to empower men to take proactive control of their reproductive health and improve survival rates through early diagnosis. The company operates primarily in the consumer health and wellness space, targeting a younger male demographic to reduce the stigma associated with testicular health monitoring.

Therapeutic areas: Oncology
Modalities: Device
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Testie Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Testie Health.

Explore the full profile